Phibro Animal Health Corporation to Host Webcast and Conference Call on Second Quarter Results
PAHCTEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its second quarter financial results on Wednesday, February 4, 2026, after the market closes. Phibro management will host a conference call and webcast on Thursday, February 5, 2026, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (8
Phibro Animal Health Corporation to Participate at Morgan Stanley Annual Global Healthcare Conference
PAHC(NASDAQ:PAHC) TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Morgan Stanley Annual Global Healthcare Conference. Chief Financial Officer, Glenn David will address financial analysts and investors on Tuesday, September 9, 2025, at 12:20 PM ET at the Sheraton New York Times Square Hotel. The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at https://investors.pahc.com. A repl
Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance
PAHCTEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June 30, 2025 and provided its financial guidance for the year ending June 30, 2026. Highlights for the three months ended June 30, 2025 (compared to the three months ended June 30, 2024) Net sales of $378.7 million, an increase of $105.5 million, or 39% Net income of $17.2 million, an increase of $16.5 million
Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2025 Results
PAHCTEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its fourth quarter and fiscal year 2025 financial results on Wednesday, August 27, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, August 28, 2025, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be availab
Morgan Stanley Maintains Equal-Weight on Phibro Animal Health, Raises Price Target to $21
PAHCPhibro Animal Health Raises FY2025 GAAP EPS Guidance from $0.96-$1.11 to $0.98-$1.11 vs $1.27 Est
PAHCPhibro Animal Health Raises FY2025 Adj EPS Guidance from $1.87-$2.01 to $1.96-$2.09 vs $1.94 Est; Narrows FY2025 Sales Guidance from $1.25B-$1.30B to $1.26B-$1.29B vs $1.28B Est
PAHCPhibro Animal Health Q3 Adj. EPS $0.63 Beats $0.52 Estimate, Sales $347.80M Miss $352.40M Estimate
PAHCCORRECTION: Phibro Animal Health Q1 Adj $0.35 Beats $0.25 Estimate, Sales $260.40M Beat $244.40M Estimate
PAHCCORRECTION: Phibro Animal Health Q1 2025 Adj. EPS $0.35 Beats $0.25 Estimate, Sales $260.400M Beat $244.400M Estimate
PAHCPhibro Animal Health Raises FY2025 Adj EPS Guidance from $1.22-1.37 to $1.34-1.48 vs $1.55 Est; Raises FY2025 Sales Guidance from $1.04B-1.09B to $1.05B-1.10B vs $1.21B Est
PAHCPhibro Sees FY25 Net Sales $1.05B-$1.1B Vs $1.21B Estimate
PAHCPhibro Animal Health Q1 2025 Adj. EPS $0.21 Misses $0.25 Estimate, Sales $260.400M Beat $244.400M Estimate
PAHCWhat's Next: Phibro Animal Health's Earnings Preview
PAHCPhibro Animal Health's Return On Capital Employed Insights
PAHCPulled from Benzinga Pro data, Phibro Animal Health (NASDAQ:PAHC) showed a loss in earnings since Q3, totaling $7.49 million. Sales, on the other hand, increased by 6.55% to $255.30 million during Q4.
Phibro Animal Health Q3 EPS $0.33 Misses $0.35 Estimate, Sales $239.60M Beat $226.26M Estimate
PAHC